busulfan has been researched along with Osteogenic Sarcoma in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Busulfan has been widely used to treat CML." | 5.40 | Busulfan inhibits growth of human osteosarcoma through miR-200 family microRNAs in vitro and in vivo. ( Li, F; Liu, Y; Mei, Q; Quan, H; Xu, H, 2014) |
| " As little data are available about the in-vitro toxicity of busulfan and treosulfan especially on pediatric tumor cell lines, we compared the cytotoxicity of treosulfan and busulfan on four Ewing tumor, four neuroblastoma, two osteosarcoma and two leukemia cell lines in vitro." | 3.73 | Cytotoxicity of treosulfan and busulfan on pediatric tumor cell lines. ( Boos, J; Bremer, A; Dirksen, U; Jürgens, H; Lanvers-Kaminsky, C, 2006) |
| "Busulfan has been widely used to treat CML." | 1.40 | Busulfan inhibits growth of human osteosarcoma through miR-200 family microRNAs in vitro and in vivo. ( Li, F; Liu, Y; Mei, Q; Quan, H; Xu, H, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Uemura, S | 1 |
| Mori, T | 1 |
| Ishiko, S | 1 |
| Takafuji, S | 1 |
| Nino, N | 1 |
| Yamamoto, N | 1 |
| Hayakawa, A | 1 |
| Nishimura, N | 1 |
| Hara, H | 1 |
| Kawamoto, T | 1 |
| Akisue, T | 1 |
| Iijima, K | 1 |
| Mei, Q | 1 |
| Li, F | 1 |
| Quan, H | 1 |
| Liu, Y | 1 |
| Xu, H | 1 |
| Lanvers-Kaminsky, C | 1 |
| Bremer, A | 1 |
| Dirksen, U | 1 |
| Jürgens, H | 1 |
| Boos, J | 1 |
| van Putten, LM | 1 |
| Kram, LK | 1 |
| van Dierendonck, HH | 1 |
| Smink, T | 1 |
| Füzy, M | 1 |
1 trial available for busulfan and Osteogenic Sarcoma
| Article | Year |
|---|---|
Retrospective analysis of high-dose chemotherapy followed by autologous stem cell transplantation for high-risk pediatric osteosarcoma.
Topics: Adolescent; Bone Neoplasms; Busulfan; Child; Female; Hematopoietic Stem Cell Transplantation; Humans | 2020 |
3 other studies available for busulfan and Osteogenic Sarcoma
| Article | Year |
|---|---|
Busulfan inhibits growth of human osteosarcoma through miR-200 family microRNAs in vitro and in vivo.
Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Bone Neoplasms; Busulfan; Cell Line, Tumor; C | 2014 |
Cytotoxicity of treosulfan and busulfan on pediatric tumor cell lines.
Topics: Antineoplastic Agents, Alkylating; Bone Neoplasms; Busulfan; Cell Survival; Humans; Leukemia; Neurob | 2006 |
Enhancement by drugs of metastatic lung nodule formation after intravenous tumour cell injection.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Busulfan; Cell Transformation, Neoplastic; Globul | 1975 |